Robert Wasserman

Stock Analyst at Benchmark

(2.06)
# 1,558
Out of 4,460 analysts
78
Total ratings
42.42%
Success rate
n/a
Average return

19 Stocks

Emergent BioSolutions
Jun 20, 2024
Maintains: Buy
Price Target: $5$8
Current: $6.06
Upside: +32.01%
Proto Labs
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $30.07
Upside: +49.65%
Intensity Therapeutics
May 16, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $4.91
Upside: +144.40%
Nephros
May 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.06
Upside: +142.72%
OmniAb
May 14, 2024
Reiterates: Buy
Price Target: $8
Current: $4.19
Upside: +90.93%
BioLife Solutions
May 13, 2024
Upgrades: Buy
Price Target: $25
Current: $19.96
Upside: +25.25%
Integer Holdings
May 10, 2024
Reiterates: Buy
Price Target: $130
Current: $115.03
Upside: +13.01%
Codexis
May 3, 2024
Reiterates: Buy
Price Target: $9
Current: $2.73
Upside: +229.67%
Bio-Techne
May 2, 2024
Reiterates: Buy
Price Target: $95
Current: $74.54
Upside: +27.45%
Halozyme Therapeutics
Apr 16, 2024
Reiterates: Buy
Price Target: $50
Current: $50.27
Upside: -0.54%
Ligand Pharmaceuticals
Apr 12, 2024
Reiterates: Buy
Price Target: $95
Current: $80.54
Upside: +17.95%
ImmunoPrecise Antibodies
Mar 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.03
Upside: +385.86%
Alterity Therapeutics
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $1.87
Upside: +113.90%
Processa Pharmaceuticals
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $1.83
Upside: +118.58%
AbCellera Biologics
Feb 22, 2024
Upgrades: Buy
Price Target: n/a
Current: $3.02
Upside: -
Repligen
Dec 4, 2023
Downgrades: Hold
Price Target: n/a
Current: $123.00
Upside: -
Anebulo Pharmaceuticals
Oct 3, 2023
Reiterates: Speculative Buy
Price Target: $8
Current: $2.05
Upside: +290.43%
Fortress Biotech
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $1.79
Upside: +4,089.94%
Danaher
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $257.51
Upside: -